NANORAD2

Radiotherapy of Multiple Brain Metastases Using AGuIX® Gadolinium-chelated Polysiloxane Based Nanoparticles: a Prospective Randomized Phase II Clinical Trial.

Open at Saint-Cloud since : 01/03/2021
Target : Adult
Phase : Phase II

Trial description

This is a Prospective Randomized Open Blinded Endpoint phase II clinical trial. The study will be adaptive: an interim analysis is planned after enrolment of 20 patients in each arm of treatment (WBRT and AGuIX« + WBRT), to select and continue the study with group(s) that present the best response rate to the experimental treatment (AGuIX« + WBRT).;The main endpoint will be evaluated by a blinded endpoint committee.

Url of the trial